Quarterly report · Q2
9989.TEDINET S100PMIV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥339.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥326.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥17.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥18.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.2bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥18.3bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥12.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥337.1bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥325.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥313.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥108.0bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥229.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥220.6bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥213.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥94.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥89.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥94.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥21.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥16.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥106.54 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.36 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥106.53 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 68.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥220.0bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥195.3bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥363.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥339.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥18.5bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥22.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥22.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥134.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥134.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥215.5bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥192.6bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥22.9bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥349.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥326.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥22.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥17.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)奥 見 正 浩 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤 本 庸 介 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 326754000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 339223000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 648734000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 18240000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 18769000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 34734000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 12455000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 12722000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 23853000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 12642000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 12737000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 24145000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 213310000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 229123000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 220592000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 313538000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 337090000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 325768000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 106.54 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 108.81 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 204.02 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 106.53 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 108.81 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 204.01 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.680 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.680 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.677 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 16805000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 21411000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 31682000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -8913000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -12048000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -20659000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -4091000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -4208000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -8187000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 90296000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 94484000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 89330000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 48.36 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 54.94 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 119331184 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 119331184 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 119331184 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 119331184 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |